$5.88 Billion is the total value of Visium Asset Management, LP's 1261 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MED | Medifast Inc | $40,757,000 | -0.6% | 1,350,000 | 0.0% | 0.69% | +12.7% | |
| ENZY | Enzymotec Ltd | $19,866,000 | -7.9% | 2,200,000 | 0.0% | 0.34% | +4.3% | |
| RDHL | Redhill Biopharma Ltd | $6,125,000 | -4.9% | 500,000 | 0.0% | 0.10% | +7.2% | |
| Accuray Incconvrt bonds | $5,296,000 | +360.9% | 5,260,000 | 0.0% | 0.09% | +429.4% | ||
| PIP | PharmAthene Inc | $3,402,000 | -0.5% | 1,800,000 | 0.0% | 0.06% | +13.7% | |
| HIIQ | Health Insurance Innovations Inc | $3,024,000 | -8.8% | 495,000 | 0.0% | 0.05% | +2.0% | |
| Sequenom Incconvrt bonds | $2,942,000 | +250.7% | 4,500,000 | 0.0% | 0.05% | +284.6% | ||
| Teleflex Incconvrt bonds | $2,558,000 | +22.0% | 1,000,000 | 0.0% | 0.04% | +37.5% | ||
| AXDX | Accelerate Diagnostics Inc | $2,156,000 | -33.1% | 150,000 | 0.0% | 0.04% | -22.9% | |
| GNMK | GenMark Diagnostics Inc | $1,581,000 | -32.1% | 300,000 | 0.0% | 0.03% | -22.9% | |
| HeartWare International Incconvrt bonds | $1,053,000 | +274.7% | 1,140,000 | 0.0% | 0.02% | +350.0% | ||
| NPD | China Nepstar Chain Drugstore Ltd | $410,000 | +1.2% | 165,969 | 0.0% | 0.01% | +16.7% | |
| NRXGQ | NephroGenex Inc | $371,000 | -70.6% | 790,000 | 0.0% | 0.01% | -68.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Altegris Advisors, LLC #1
- Compass TPM LLC #2
- Compass Offshore TPM LP #3
- Catalyst Investment Management Co., LLC #4
- JG Asset, LLC #5
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 13 | Q2 2016 | 1.9% |
| GRIFOLS SA-ADR | 13 | Q2 2016 | 1.3% |
| YAHOO! INC | 13 | Q2 2016 | 1.6% |
| DANAHER CORP | 13 | Q2 2016 | 0.8% |
| American International Group Inc | 13 | Q2 2016 | 0.7% |
| ASHLAND INC | 13 | Q2 2016 | 0.4% |
| B/E AEROSPACE INC | 13 | Q2 2016 | 0.3% |
| HONEYWELL INTERNATIONAL INC | 13 | Q2 2016 | 0.4% |
| E*TRADE FINANCIAL CORP | 13 | Q2 2016 | 0.6% |
| HEALTHSOUTH CORP | 13 | Q2 2016 | 0.2% |
View Visium Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ALBANY MOLECULAR RESEARCH INCSold out | February 14, 2017 | 0 | 0.0% |
| APPLIED GENETIC TECHNOLOGIES CORPSold out | February 14, 2017 | 0 | 0.0% |
| AQUINOX PHARMACEUTICALS, INCSold out | February 14, 2017 | 0 | 0.0% |
| Ascendis Pharma A/SSold out | February 14, 2017 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| Axovant Sciences Ltd.Sold out | February 14, 2017 | 0 | 0.0% |
| Bioblast Pharma Ltd.Sold out | February 14, 2017 | 0 | 0.0% |
| CONMED CORPSold out | February 14, 2017 | 0 | 0.0% |
| CymaBay Therapeutics, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| Enzymotec Ltd.Sold out | February 14, 2017 | 0 | 0.0% |
View Visium Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
| SC 13G/A | 2017-02-14 |
View Visium Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.